Subject: 615.105 - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Subject 615.105

10271. What are our pharmacotherapeutic options for MERS-CoV?. Issue 3 (May 2014)

Authors:: Al-Tawfiq, Jaffar A; Memish, Ziad A
Journal:: Expert review of clinical pharmacology
Issue:: Volume 7:Issue 3(2014)
Page Start:: 235
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10272. What are the chances that resveratrol will be the drug of tomorrow?. (March 2018)

Authors:: Gliemann, Lasse
Journal:: Pharmacological research
Issue:: Volume 129(2018)
Page Start:: 139
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10273. What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?. Issue 11 (1st November 2016)

Authors:: Atzeni, Fabiola; Benucci, Maurizio; Talotta, Rossella; Masala, Ignazio Francesco; Sarzi-Puttini, Piercarlo; Govoni, Marcello
Journal:: Expert review of clinical pharmacology
Issue:: Volume 9:Issue 11(2016)
Page Start:: 1403
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10274. What are they waiting for?—Tethered agonism in G protein-coupled receptors. (June 2016)

Authors:: Schöneberg, Torsten; Kleinau, Gunnar; Brüser, Antje
Journal:: Pharmacological research
Issue:: Volume 108(2016:Jun.)
Page Start:: 9
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10275. What are they waiting for?—Tethered agonism in G protein-coupled receptors. (June 2016)

Authors:: Schöneberg, Torsten; Kleinau, Gunnar; Brüser, Antje
Journal:: Pharmacological research
Issue:: Volume 108(2016:Jun.)
Page Start:: 9
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10276. What Canadians are saying about Pharmacare. (September 2015)

Authors:
Journal:: Canadian pharmacists journal
Issue:: Volume 148:Number 5(2015)
Page Start:: 288
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10277. What does it take to change practice? Perspectives of pharmacists in Ontario. (January 2018)

Authors:: Gregory, Paul A. M.; Teixeira, Beatriz; Austin, Zubin
Journal:: Canadian pharmacists journal
Issue:: Volume 151:Number 1(2018)
Page Start:: 43
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10278. What does the pharmacological future of treating chronic hepatitis C look like?. Issue 5 (September 2015)

Authors:: Heil, Emily L; Hynicka, Lauren M; Kottilil, Shyam; Tang, Lydia
Journal:: Expert review of clinical pharmacology
Issue:: Volume 8:Issue 5(2015)
Page Start:: 605
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10279. What if there were no new antibiotics? A look at alternatives. Issue 12 (1st December 2016)

Authors:: Rello, Jordi; Bunsow, Eleonora; Perez, Antonio
Journal:: Expert review of clinical pharmacology
Issue:: Volume 9:Issue 12(2016)
Page Start:: 1547
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10280. What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis. (July 2020)

Authors:: Ding, Hongda; Zhang, Yingshi; Zhao, Liang; Wu, Si; Liu, Junpeng; Wang, Caibin; Pei, Tong; Su, Yang
Journal:: Pharmacological research
Issue:: Volume 157(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗